Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance.

Reger de Moura, Coralie; Prunotto, Marco; Sohail, Anjum; Battistella, Maxime; Jouenne, Fanelie; Marbach, Daniel; Lebbé, Celeste; Fridman, Rafael; Mourah, Samia

Reger de Moura, Coralie; Prunotto, Marco; Sohail, Anjum; Battistella, Maxime; Jouenne, Fanelie; Marbach, Daniel; Lebbé, Celeste; Fridman, Rafael; Mourah, Samia.

Afiliação

Reger de Moura C; Laboratory of Pharmacogenomics, Hôpital Saint-Louis, AP-HP, Paris, France.
Prunotto M; INSERM, UMR_S976, Université de Paris, Paris, France.
Sohail A; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Battistella M; Department of Pathology, School of Medicine, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States.
Jouenne F; INSERM, UMR_S976, Université de Paris, Paris, France.
Marbach D; Department of Pathology, Hôpital Saint-Louis, AP-HP, Paris, France.
Lebbé C; Laboratory of Pharmacogenomics, Hôpital Saint-Louis, AP-HP, Paris, France.
Fridman R; INSERM, UMR_S976, Université de Paris, Paris, France.
Mourah S; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.